Autio K - Search Results

1

Balancing Hormone Therapy: Mitigating Adverse Effects of Androgen-Deprivation Therapy and Exploring Alternatives in Prostate Cancer Management.

Gudenkauf LM, Gray S, Gonzalez BD, Sachdeva A, Autio K. Gudenkauf LM, et al. Among authors: autio k. Am Soc Clin Oncol Educ Book. 2024 Jun;44(3):e433126. doi: 10.1200/EDBK_433126. Am Soc Clin Oncol Educ Book. 2024. PMID: 38788186 Free article. Review.

2

Response of albumin synthesis to oral nutrients in young and elderly subjects.

Caso G, Feiner J, Mileva I, Bryan LJ, Kelly P, Autio K, Gelato MC, McNurlan MA. Caso G, et al. Among authors: autio k. Am J Clin Nutr. 2007 Feb;85(2):446-51. doi: 10.1093/ajcn/85.2.446. Am J Clin Nutr. 2007. PMID: 17284742 Free article. Clinical Trial.

3

Therapeutic strategies for bone metastases and their clinical sequelae in prostate cancer.

Autio KA, Scher HI, Morris MJ. Autio KA, et al. Curr Treat Options Oncol. 2012 Jun;13(2):174-88. doi: 10.1007/s11864-012-0190-8. Curr Treat Options Oncol. 2012. PMID: 22528368 Free PMC article. Review.

4

Targeting bone physiology for the treatment of metastatic prostate cancer.

Autio KA, Morris MJ. Autio KA, et al. Clin Adv Hematol Oncol. 2013 Mar;11(3):134-43. Clin Adv Hematol Oncol. 2013. PMID: 23598981 Free PMC article. Review.

5

High-risk prostate cancer-classification and therapy.

Chang AJ, Autio KA, Roach M 3rd, Scher HI. Chang AJ, et al. Nat Rev Clin Oncol. 2014 Jun;11(6):308-23. doi: 10.1038/nrclinonc.2014.68. Epub 2014 May 20. Nat Rev Clin Oncol. 2014. PMID: 24840073 Free PMC article. Review.

6

Targeting the androgen receptor in prostate and breast cancer: several new agents in development.

Proverbs-Singh T, Feldman JL, Morris MJ, Autio KA, Traina TA. Proverbs-Singh T, et al. Endocr Relat Cancer. 2015 Jun;22(3):R87-R106. doi: 10.1530/ERC-14-0543. Epub 2015 Feb 26. Endocr Relat Cancer. 2015. PMID: 25722318 Free PMC article. Review.

7

Immune Checkpoint Blockade for Prostate Cancer: Niche Role or Next Breakthrough?

de Almeida DVP, Fong L, Rettig MB, Autio KA. de Almeida DVP, et al. Am Soc Clin Oncol Educ Book. 2020 Mar;40:1-18. doi: 10.1200/EDBK_278853. Am Soc Clin Oncol Educ Book. 2020. PMID: 32343604 Free article. Review.

8

Androgen Deprivation Therapy Drives a Distinct Immune Phenotype in Localized Prostate Cancer.

Dallos MC, Obradovic AZ, McCann P, Chowdhury N, Pratapa A, Aggen DH, Gaffney C, Autio KA, Virk RK, De Marzo AM, Antonarakis ES, Scher HI, Drake CG, Rathkopf DE. Dallos MC, et al. Among authors: autio ka. Clin Cancer Res. 2024 Nov 15;30(22):5218-5230. doi: 10.1158/1078-0432.CCR-24-0060. Clin Cancer Res. 2024. PMID: 39269310

9

Repetitively dosed docetaxel and ¹⁵³samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer.

Autio KA, Pandit-Taskar N, Carrasquillo JA, Stephenson RD, Slovin SF, Rathkopf DE, Hong C, Heller G, Scher HI, Larson SM, Morris MJ. Autio KA, et al. Cancer. 2013 Sep 1;119(17):3186-94. doi: 10.1002/cncr.28103. Epub 2013 Jun 13. Cancer. 2013. PMID: 23765638 Free PMC article.

10

Monitoring the clinical outcomes in advanced prostate cancer: what imaging modalities and other markers are reliable?

Morris MJ, Autio KA, Basch EM, Danila DC, Larson S, Scher HI. Morris MJ, et al. Semin Oncol. 2013 Jun;40(3):375-92. doi: 10.1053/j.seminoncol.2013.04.008. Semin Oncol. 2013. PMID: 23806501 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters